PharmaPrint Moving Toward In-House Manufacturing Capability
This article was originally published in The Tan Sheet
Executive Summary
PharmaPrint is consolidating its manufacturing operations through an agreement with the contract manufacturer Lone Star Pharmaceuticals, the dietary supplement developer and marketer announced Aug. 16. The deal will serve as a stepping stone toward the construction of an in-house PharmaPrint production and laboratory facility.
You may also be interested in...
PharmaPrint
Six vitamin/herbal combination products to be sold on HealthZone.com beginning this month. The line, which includes vitamin/herbal formulations of echinacea, garlic, ginkgo biloba, ginseng, saw palmetto and St. John's wort, will be marketed under the PharmaPrint brand. HealthZone.com also will carry information on the proprietary PharmaPrint "fingerprinting" technology and a direct link to the Irvine, Calif.-based company's nearly completed Web site. PharmaPrint plans to partner with more e-commerce distributors in the coming months and intends to sell private label combination products to mass merchandisers (1"The Tan Sheet" Aug. 23, p. 9)
PharmaPrint
Company begins tests to standardize soy's active ingredients and total bioactivity. The Irvine, Calif.-based firm says it is using the same process by which it developed the Centrum Herbals line for American Home Products
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC